| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.036 | 0.5 |